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Abstract
Background: While an increase in bone marrow adiposity is associated with age-related bone disease, the function
of bone marrow adipocytes has not been studied. The aim of this study was to characterize and compare the age-
related gene expression profiles in bone marrow adipocytes and epididymal adipocytes.
Results: A total of 3918 (13.7%) genes were differentially expressed in bone marrow adipocytes compared to
epididymal adipocytes. Bone marrow adipocytes revealed a distinct gene profile with low expression of adipocyte-
specific genes peroxisome proliferator-activated receptor gamma (PPARg), fatty acid binding protein 4 (FABP4),
perilipin (Plin1), adipsin (CFD) and high expression of genes associated with early adipocyte differentiation (CCAAT/
enhancer binding protein beta (C/EBPb), regulator of G-protein signaling 2 (RGS2). In addition, a number of genes
including secreted frizzled related protein 4 (SFRP4), tumor necrosis factor a (TNFa), transforming growth factor beta
1(TGFb1), G-protein coupled receptor 109A (GPR109A) and interleukin 6 (IL-6), that could affect adipose-derived
signaling to bone are markedly increased in bone marrow adipocytes. Age had a substantial effect on genes
associated with mitochondria function and inflammation in bone marrow adipocytes. Twenty seven genes were
significantly changed with age in both adipocyte depots. Among these genes, IL6 and GPR109A were significantly
reduced with age in both adipocyte depots.
Conclusions: Overall, gene profiling reveals a unique phenotype for primary bone marrow adipocytes
characterized by low adipose-specific gene expression and high expression of inflammatory response genes. Bone
marrow and epididymal adipocytes share a common pathway in response to aging in mice, but age has a greater
impact on global gene expression in epididymal than in bone marrow adipocytes. Genes that are differentially
expressed at greater levels in the bone marrow are highly regulated with age.
Background
Aging is associated with impaired adipogenesis in various
fat depots in humans [1-4]. With age and age-related
osteoporosis, there is an inverse relationship between bone
mass and bone marrow adiposity [5-7]. There are generally
considered to be two types of adipose tissue, white and
brown, both of which are able to store lipid but have dif-
ferent roles in energy metabolism [8,9]. Moreover, there
are regional differences in the function among various adi-
pose tissue depots; in humans visceral obesity presents a
greater risk for obesity-related metabolic disease than sub-
cutaneous obesity [10,11].
Previous functional studies of marrow adipocytes have
mostly been limited to developmental studies [12]. Some
studies have suggested that the presence of adipocytes can
influence differentiation of mesenchymal stem cells
(MSCs) into adipocytes, thereby inhibiting the differentia-
tion into other cell lines [13]. We and others reported that
directly co-culturing bone marrow MSCs with fully differ-
entially adipocytes decreased osteoblast differentiation by
decreasing RunX2 mRNA expression [14,15], suggesting
that these cells are metabolically active but negatively reg-
ulate differentiation of MSCs into osteoblasts. Recent stu-
dies have suggested that, in addition to adipose, liver and
muscle tissue, the osteoblast is also an important target
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any medium, provided the original work is properly cited.tissue for insulin action [16,17]. Infiltration of fat in bone
marrow could affect osteoblast function and differentiation
through paracrine/endocrine effects of secretory products
and adipocytokines [18,19]. Thus, bone marrow adipocytes
might play a pivotal role in mediating the regulation of
osteoblast function in aging and in diabetic or obese ani-
mals. A recent report demonstrated that bone marrow-
derived adipocytes are distinct from epididymal white
adipocytes [20]. While it is well known that ectopic fat
accumulation in non-adipose tissues is greatly associated
with age-related insulin resistance and metabolic disorders
[21], the relationship of bone marrow adiposity with age-
related diseases is unclear. In view of the specialized envir-
onment within the bone marrow with both active hemato-
poiesis and osteoblastogenesis ongoing, we hypothesized
that adipocytes within the bone marrow might constitute
a unique depot. In order to obtain a comprehensive
understanding of the characteristics of bone marrow adi-
pocytes, we profiled the gene expression patterns in
bone marrow adipocytes witha g ea n ds i m u l t a n e o u s l y
examined differential gene expression in bone marrow and
epididymal adipocytes with age. This study is the first to
characterize primary bone marrow adipocytes and to
demonstrate the effects of aging on two different adipocyte
populations within the same animal. Our results demon-
strate that while bone marrow adipocytes are distinct from
epididymal white adipocytes, they also share a common
inflammatory pathway in response to aging.
Results
Table 1 depicts several metabolic and biochemical para-
meters of the mice included in these studies. The meta-
bolic parameters showed the expected negative effects of
age on mice. Thus, there was a significant increase in
weight and serum insulin and glucose levels in older mice
compared to 6 month old animals. These negative
metabolic effects of age were accompanied with significant
increases in fat infiltration into bone marrow, as shown in
Figure 1. Similarly, there were significant increases in lep-
tin and adiponectin with age along with a significant
decrease in circulating osteocalcin with age, whereas resis-
tin, RANKL (receptor activator for nuclear factor B
ligand) and osteoprotegerin showed no changes with age.
Adipocyte-specific genes in bone marrow adipocytes
Bone marrow adipocytes were isolated by flushing out
bone marrow cells from femurs and tibias and then iso-
lating the adipocytes by flotation. White adipocytes were
isolated from epididymal adipo s et i s s u eb yf l o t a t i o nf o l -
lowing collagenase digestion. Figure 2A displays the char-
acteristics of the adipocyte cell preparations from bone
marrow and epididymal depots. Epididymal adipocytes
tended to be larger, but both adipocyte populations
stained neutral lipids with Bodipy. In order to evaluate
the degree of contamination of the cell preparations with
monocyte/macrophages, the percentage of monocytes
present in the samples was determined by identifying the
number of CD11b positive cells. Approximately 10-17%
of cells were identified as CD11b positive in both bone
marrow and epididymal white adipocyte preparations
(Figure 2A). In addition, the adipocytes from both bone
marrow and epididymal depots stained with perilipin, but
epididymal adipocytes had greater immunostaining. We
verified the expression of a select group of adipocyte spe-
cific genes in the isolated adipocytes by RT-PCR (Reverse
transcription polymerase chain reaction). FABP4 (fatty
acid binding protein 4, adipocyte), perilipin (Plin1),
ADFP (Plin2), leptin, adiponectin and C/EBPb (CCAAT/
enhancer binding protein beta) were all much more
highly expressed in bone marrow adipocytes compared
to the non-floating bone marrow stromal cells, as would
be expected for adipocyte specific genes (Figure 2B).
However, all of these genes, except C/EBPb,w e r e
expressed at relatively lower levels in bone marrow com-
pared to epididymal adipocytes. The differences in
expression levels between bone marrow and epididymal
adipocytes determined by qRT-PCR were mostly in
agreement with the microarray data obtained (see below).
Global characteristics of bone marrow adipocytes
We analyzed the differential expression of adipocyte genes
isolated from bone marrow and epididymal fat depots
from adult (6-month-old) and aged mice (14-and 18-
month-old) using microarrays. Inspection of the frequency
of expression values after normalization of the data
showed consistent values between all samples (Additional
File 1, Figure S1). Principal component analysis revealed a
visible separation between bone marrow and epididymal
adipocytes (Figure 3A). Moreover, there is a clear separa-
tion between epididymal adipocytes from 18-month and
Table 1 Metabolic parameters in aging mice
Parameter 6-month 14-month
Weight (g) 35.0 ± 1.2 41.8 ± 4.0*
Insulin (ng/mL) 0.57 ± 0.16 2.09 ± 0.44*
Glucose (mg/dL) 118.7 ± 12 192.7 ± 17*
Triglyceride (mg/dL) 240.9 ± 3.43 250.7 ± 6.8
Adipokines
Leptin (ng/mL) 3.52 ± 0.77 20.7 ± 2.38*
Resistin (ng/mL) 1.35 ± 0.17 1.85 ± 0.20
Adiponectin (μg/mL) 2.90 ± 0.20 5.66 ± 0.74*
Bone panel
Osteocalcin (ng/mL) 54.4 ± 4.8 31.8 ± 6.8*
RANKL (ng/mL) 0.21 ± 0.03 0.17 ± 0.22
Osteoprotegerin (ng/mL) 2.28 ± 0.40 1.92 ± 0.17
Data are mean ± SE of 6 to 10 mice per age group. Body weights were
determined at time of necropsy. Serum metabolites were measured in the fed
state. * P < 0.05 vs. 6-month-old.
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Page 2 of 18younger mice. This clustering represents the overall
expression patterns, but does not provide the expression
of individual genes. Analysis of genes based on functional
category was performed to measure the differences and
the similarities between the two adipocyte populations. A
total of 3918 (13%) of the 28853 well-characterized mouse
genes were differentially expressed between the two adipo-
cyte populations. This selection was based on adjusted p <
0.05 and a fold change ± 2.0. These 3918 genes were
assigned to biologically meaningful gene ontology (GO)
Figure 1 Quantitative analysis of bone marrow adipocytes. A. The top panels are images of the distal femurs from 6-month-old and 14-
month-old C57BL6/J male mice stained with H&E (magnification ×5). The bottom panels are sections stained with H&E showing the numerous
large adipocytes in bone marrow from distal femurs (magnification ×20). B. Area of bone marrow fat infiltration as a % of total area. C. Numbers
of bone marrow fat cells (numbers/mm
2 bone marrow). Fields were taken from distal femur sections of 6-month-old and 14-month-old mice
and calculated using ImagePro software.
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Page 3 of 18categories. Differences in gene expression between bone
marrow and epididymal adipocytes were primarily
observed in three categories: biological process, molecular
function and cellular component (Table 2). Subcategories
of biological process include regulation of cell cycle, cell
death and cell differentiation and regulation of metabolic
processes, for instance carbohydrate and lipid metabolism,
whereas molecular function includes genes associated with
protein binding, enzyme activity and transcription regula-
tor activity, and cellular component includes genes
that are associated with the cell membrane, extracellular
matrix, synapses and membrane bound organelles. The
table displays the enrichment score and p-value in subca-
tegories of the overall category of biological processes that
are most relevant to adipocyte-specific functions, whereas
the subcategories of cellular component and molecular
function are not shown because the p-value of these over-
all categories did not reach statistical significance. As
shown in Table 2, fat cell differentiation comprised 71-
74% of genes in the ontology functional analysis. We next
loaded this set of 3918 genes differentially expressed in the
bone marrow and epididymal adipocytes into Ingenuity
Pathway Analyses for further biological functional analysis.
A set of 277 genes was generated by filtering expression in
adipose tissue. This set of genes displayed a substantial dif-
ferential expression pattern between bone marrow and
epididymal adipocytes (Table 3). Table 3 displays the
genes that were most differentially expressed and that are
associated with network and biological pathways in adipo-
cytes. Of these 277 genes, supervised hierarchical cluster-
ing of 28 genes that are associated with the adipocyte
phenotype revealed that all were expressed in bone mar-
row adipocytes and that their expression patterns differed
markedly from epididymal adipocytes (Figure 3B). In con-
trast to Figure 3A, there appears to be a separation
between 6-month-old and elder mice in expression of
some of these adipose-specific genes in epididymal adipo-
cytes in Figure 3B; however, it is important to note that
Figure 3A represents global, not individual, gene
differences.
Functional analysis of differential gene expression
between bone marrow and epididymal white adipocytes
We further analyzed the over-represented 3918 genes (2-
fold change) by GO enrichment( P a r t e k )a n dI n g e n u i t y
Pathway analyses. Among these genes, a set of 1940 genes
was decreased greater than 2-fold (p ≤ 0.05) in bone mar-
row adipocytes compared with epididymal adipocytes
across age. Of these 1940 genes, there were 547 genes
associated with bio-functional groups and networks. This
set of genes was enriched and associated with lipid meta-
bolism, molecular transport and small molecule biochem-
istry. Figure 4A shows a supervised hierarchal cluster of
genes related to adipocyte lipid metabolism, including
Figure 2 Characterization of adipocyte preparations isolated from bone marrow and epididymal depots.A .L i g h ta n d
immunofluorescence microscopy of adipocytes isolated from bone marrow and epididymal white adipose tissue. Fixed cells were incubated
with either BODIPY 493/503 (1:500) or PE (phycoerythrin) conjugated anti-mouse CD11b (Intergrin a, Mac-1a) and polyclonal anti rabbit perilipin
antibodies (1:200) in 1% blocking solution for 1 h. Following 1 h incubation of Alexa 555 (red) conjugated secondary antibodies at a dilution of
1/800 at room temperature, the stained cells were washed three to four times with PBS and observed using a Zeiss microscope observer A1. B.
Expression of selected adipose genes in preparations of bone marrow cells, adipocytes isolated from bone marrow and adipocytes isolated from
epididymal adipose tissue. A set of original RNA from the same animal was re-amplified to aRNA, then converted to cDNA. Relative fold change
was normalized to endogenous 18S and bone marrow stromal cells. Data are presented as Log2 of fold change.
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Page 4 of 18Figure 3 Bone marrow adipocytes are distinct from epididymal adipocytes. Bone marrow adipocytes and epididymal adipocytes were
isolated from the same mice (age 6-month, 14-month and 18-month-old). Cells from several animals were pooled to yield sufficient sample to
analyze three arrays for each age group and both adipocyte populations. A total of 18 arrays were included in the microarray analysis. A.
Principal component analysis of array data before normalization showing clustering of bone marrow adipocytes as separate from epididymal
adipocytes. B. Supervised hierarchical cluster analysis of 27 genes in adipocyte differentiation following normalization of all data sets.
Table 2 Gene ontologies with differentially expressed genes in bone marrow adipocytes
Functional Group Enrichment Score* P value** % genes in group present
Biological process 4.39 0.01 18.10
Cellular 40.9 <0.001 21.9
Immune system 18.36 <0.001 31.7
Metabolic 16.67 <0.001 20.7
Oxidation reduction 37.36 <0.001 30.52
Lipid 23.63 <0.001 34.7
Carbohydrate 7.41 <0.001 28.05
Developmental 4.3 0.01 19.71
Adipocyte differentiation 18.3 <0.001 47.27
Brown 31.44 <0.001 74.07
White 8.46 <0.001 71.43
Cellular component 3.55 0.03 17.97
Molecular component 1.80 0.17 17.91
A selection of genes generated from ANOVA analysis was assigned to biologically meaningful gene ontology (GO) categories using GO enrichment analysis
(Partek
® Genome Suite software, version 6.3). Listed are groups of gene-associated biological processes in bone marrow adipocytes compared with epididymal
adipocytes (fold change cut off is 2.0). *A high value of enrichment score indicates that the functional group is over-represented in the gene list. **P value is the
-log p-value of a Chi-square test.
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Page 5 of 18fatty acid synthesis (upper panel) and oxidation (lower
panel), that were 2-fold lower in bone marrow adipocytes.
This gene set included leptin, Acsl1 (acyl-coA synthetase
1), adiponectin and Scap (SREBF chaperone) in fatty acid
synthesis and PPARa,P G C 1 a,C P T 1 a and ACOX1 in
fatty acid oxidation. Clustering also highlighted a group of
1965 genes that were increased 2-fold or more in bone
marrow adipocytes. Of these 1965 genes, there were 337
genes associated with biological function networks. These
genes are associated with pro-apoptosis, pro-inflammatory
cytokines and mitochondrial dysfunction. As listed in
Table 3, genes displaying increased expression in bone
marrow adipocytes include leptin receptor (Lepr), G-pro-
tein coupled receptor 109A (GPR109A) and gp-130 cyto-
kines, oncostatin M (OM), interleukin 6 (IL-6) and TNFa.
Adipocyte specific genes (PPARg, FABP4, perilipin, adipsin
and leptin) were expressed at significantly lower levels in
bone marrow adipocytes compared with epididymal adipo-
cytes. Figure 4B shows a supervised hierarchal cluster of
11 genes associated with decreases in transmembrane
potential of mitochondria and apoptosis. These genes
included p53, IL1b (interleukin 1b), BCL2L11 (BCL2-like
11, apoptosis facilitator protein), UCP2 and TGFb1. Figure
4C shows a supervised cluster of 11 genes associated with
Table 3 Comparison of adipocyte-genes between bone marrow and epididymal adipocytes
Symbol Entrez Gene Name 6-month 14-month 18-month
Increased expression in bone marrow
LEPR leptin receptor 19.7 7.4 16.4
OSM oncostatin M 18.1 20.1 11.4
RGS2 regulator of G-protein signaling 2, 24kDa 15.3 15.8 8.9
SFRP4 secreted frizzled-related protein 4 14.8 1.8 6.6
ABCB4 ATP-binding cassette, sub-family B, member 4 10.7 6.9 7.4
TNFRSF1b CD120b 6.6 4.3 8.3
TNFa tumor necrosis factor a 5.0 26.3 7.2
100001G20RIK RIKEN cDNA 1100001G20 gene, Wdnm1-like 4.2 4.5 3.0
UCP2 uncoupling protein 2 4.0 2.1 3.7
LPIN2 lipin 2 4.0 3.9 5.6
TGFB1 transforming growth factor, beta 1 3.9 2.5 3.8
GPR109A G protein-coupled receptor 109A 3.7 33.6 2.3
C/EBPb CCAAT/enhancer binding protein beta 2.3 6.8 1.3
IL6 interleukin 6 -1.1* 8.8 2.8
Decreased expression in bone marrow
LEP leptin -152.5 -300.1 -454.4
CFD complement factor D (adipsin) -138.2 -115.9 -107.1
RETN resistin -114.7 -87.4 -153.7
CDO1 cysteine dioxygenase, type I -106.9 -132.3 -192.1
PLIN1 perilipin 1 -100.6 -85.1 -106.5
ERPINE1 plasminogen activator inhibitor type 1 -60.9 -7.0 -19.0
FASN fatty acid synthase -32.9 -28.5 -43.5
ADIPOQ adiponectin -26.4 -35.3 -41.2
FABP4 fatty acid binding protein 4, adipocyte -23.2 -27.0 -41.3
LIPE lipase, hormone-sensitive -21.9 -15.2 -26.8
LPL lipoprotein lipase -21.8 -18.8 -23.9
KLB klotho beta -21.1 -12.9 -29.6
ACOX1 acyl-Coenzyme A oxidase 1, palmitoyl -16.5 -10.2 -12.8
FGFR1 fibroblast growth factor receptor 1 -12.2 -11.4 -10.2
SLC2A4 glucose transporter member 4 -10.2 -9.5 -9.2
C/EBPa CCAAT/enhancer binding protein, alpha -6.7 -8.7 -11.2
PPARg peroxisome proliferator-activated receptor gamma -5.9 -4.8 -10.3
IDH1 isocitrate dehydrogenase 1 (NADP+), soluble -5.1 -4.7 -6.4
ADIPOR2 adiponectin receptor 2 -4.7 -4.0 -4.7
The list includes the most differentially expressed genes in bone marrow adipocytes compared to epididymal adipocytes. The set of the significantly differentially
expressed genes was selected on the basis of their expression in adipose cells according to the IPA knowledge-base. For each gene, the fold change valuei n
gene expression was calculated between mean values in bone marrow adipocytes versus epididymal adipocytes in mice (6-month, 14-month and 18-month old).
The significance of differences was measured by one-way ANOVA. All values are p < 0.01 except * P > 0.01
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Page 6 of 18early adipocyte differentiation. These genes include EGR1
(early growth response 1, Krox-1), EGR2 (early growth
response 2, Krox-20), KLF5 (Kruppel-like factor 5),
INHBA (inhibin beta A, activin), CEBP/b and RPS6KA1
(ribosomal protein S6 kinase 1).
Age-related alteration of gene expression in bone
marrow and epididymal white adipocytes
We next sought to identify genes affected by aging within
each adipocyte population based on ontology. Aging-
related alterations of gene expression were identified and a
list of genes was generated yielding a total of 5649 genes
that displayed significant changes in both bone marrow and
epididymal adipocytes with age. Analyses were conducted
using two-way ANOVA including interaction of cell types
and age. The comparisons were conducted by comparing
14-month-old and 18-month-old to 6-month-old. Genes
were further analyzed by Ingenuity Pathway Analyses to
relate age-associated gene expression changes to biological
function and signaling pathways. Age-related gene changes
Figure 4 Heat maps of genes differentially expressed in bone marrow adipocytes. A. Clustering of genes involved in lipid metabolism
(fatty acid synthesis, upper panel, and fatty acid oxidation, lower panel) with at least a 2-fold difference between bone marrow adipocytes
compared with epididymal adipocytes. B. Clustering of genes involved in decreased transmembrane potential of mitochondria with at least a 2-
fold difference between bone marrow adipocytes compared with epididymal adipocytes. C. Clustering of genes involved in early adipocyte
differentiation with at least a 2-fold difference between bone marrow adipocytes compared with epididymal adipocytes.
Liu et al. BMC Genomics 2011, 12:212
http://www.biomedcentral.com/1471-2164/12/212
Page 7 of 18in adipocytes fell into several categories of biological func-
tion including inflammatory response, genetic disorder and
cellular development, whereas the majority of alterations of
genes in both adipocyte depots were associated with mito-
chondrial dysfunction and lipid metabolism. Figure 4A
shows that genes involved in fatty acid synthesis were
increased with age in bone marrow adipocytes, including
Acss1 (acyl-coA synthetase short chain family 1), Fads2
(fatty acid desaturase 2), and Slc27a4 (fatty acid transporter
4). Heat maps of age-altered genes in the bone marrow and
epididymal adipocytes are indicated in Figure 5. Figure 5A
illustrates age-related changes in genes involved in mito-
chondria function in which 18-month-old bone marrow
adipocytes and epididymal adipocytes were most affected.
Figure 5B displays the differential expression of genes
involved in lipolysis in response to aging in both adipocyte
populations. TNFa, Plin3 and Lipe (hormone sensitive
lipase) increased in 14-month-old bone marrow adipocytes,
whereas most of these genes decreased in 14-month-old
epididymal adipocytes. PNPLA2 (ATGL) was decreased
with age in both adipocyte depots. As shown in Table 4,
pathways and networks associated with adipocyte differen-
tiation, lipolysis and mitochondria function displayed signif-
icant changes with age in adipocytes. Approximately 60
percent of genes associated with adipocyte differentiation
were significantly up-regulated in 14-month-old bone mar-
row adipocytes, whereas 70 percent of genes were down-
regulated in 14-month-old epididymal adipocytes. A similar
pattern was also observed in lipolysis pathways. In addition,
a group of genes associated with mitochondria function
was significantly regulated in bone marrow adipocytes
with age, but not in epididymal adipocytes, as indicated in
Table 4. Fold change values of genes involved in adipocyte
differentiation, lipolysis and mitochondrial function are
listed in Tables 5, 6 and 7.
As indicated in Table 4, differential gene expression pro-
filing was observed between bone marrow and epididymal
adipocytes in pathway analysis. In order to examine the
differences with age between bone marrow and epididymal
adipocytes, we analyzed the fold changes with age in each
adipocyte population separately. Table 8 shows the top-
regulated adipocyte genes in bone marrow adipocytes with
age. This list indicates that adiponectin and IL6 were
the most down-regulated genes, while TNFa and genes
associated with fatty acid transport and lipolysis, such as
CD36 and Lipe (hormone sensitive lipase, HSL), were up-
regulated. The increases in CD36 and HSL were not
observed in epididymal adipocytes. On the other hand,
Table 9 indicates that lipid droplet associated proteins
Plin2 and Plin3 were significantly increased with age in
epididymal white adipocytes, whereas Plin 3, but not
Plin2, was significantly altered in bone marrow adipocytes.
In addition, some adipocyte-specific genes (PPARg, Plin3
and CEBPb) increased in 14-month-old, then decreased in
the 18-month-old group in bone marrow adipocytes,
whereas they were not altered in the same direction in epi-
didymal adipocytes (Tables 8 and 9).
Furthermore, in order to determine the most highly
regulated adipocyte-specific genes in response to aging
that are common to both adipocyte populations, we
Figure 5 Age-related gene expression in adipocytes. Heat maps of age-associated gene expression changes in bone marrow and epididymal
white adipocytes. A. Clustering of genes involved in mitochondria function. B. Clustering of genes associated with lipolysis. C. Clustering of age-
regulated genes in bone marrow and epididymal adipocytes.
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Page 8 of 18Table 4 Top regulated pathways in bone marrow and epididymal adipocytes with age
Genes Genes assigned
Pathway Cell type Age (M) Up Down In pathway Ratio* -Log10 (p value)**
Adipocyte differentiation Bone marrow 14M 18 12 30 0.36 1.922
18M 11 19 0.486 4.436
Epididymal 14M 9 21 30 0.61 6.019
18M 8 22 0.46 2.498
Lipolysis Bone marrow 14M 6 7 13 0.289 1.347
18M 5 8 0.263 0.87
Epididymal 14M 2 11 13 0.342 1.203
18M 2 11 0.289 0.659
Mitochondria dysfunction Bone marrow 14M 12 18 30 0.237 1.115
18M 13 17 0.323 3.364
Epididymal 14M 3 27 30 0.24 0.487
18M 21 9 0.226 0.28
For each gene, the fold change of expression of 14-month-old (14M) and 18-month-old (18M) was calculated versus 6-month-old (6M). Pathways that have
significant association with the whole set of regulated genes in bone marrow and epididymal adipocytes with age were assessed using IPA software. * Ratio of
altered genes in bone marrow adipocytes to assigned pathway. **The p-value was calculated by IPA using Fisher’s Exact Test. A threshold of 1.30 was selected
(p < 0.05)
Table 5 Age-associated fold changes in genes involved in adipocyte differentiation
Bone marrow Epididymal
Symbol Entrez Gene Name 14M 18M 14M 18M
AR androgen receptor -1.84 -2.03 -1.47 -1.82
ARL4A ADP-ribosylation factor-like 4A -1.34 1.28 -2.04 1.03
CCND1 cyclin D1 1.26 1.11 2.48 -1.64
CEBPA CCAAT/enhancer binding protein (C/EBP), alpha -1.51 -1.43 -1.33 1.15
DDIT3 DNA-damage-inducible transcript 3 1.22 -2.14 -1.76 -1.16
EBF1 early B-cell factor 1 1.43 -1.50 -1.28 -1.41
EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3 1.80 1.17 1.70 1.53
FABP4 fatty acid binding protein 4, adipocyte -1.54 -2.57 -1.23 -1.32
FGF10 fibroblast growth factor 10 1.23 1.18 -2.60 1.04
FN1 fibronectin 1 1.36 -1.18 7.06 -3.16
IL6 interleukin 6 (interferon, beta 2) -2.04 -2.07 -20.53 -5.56
IL1B interleukin 1, beta 1.37 -1.48 -2.26 -2.16
INSIG1 insulin induced gene 1 1.26 1.49 1.33 2.81
IRS2 insulin receptor substrate 2 1.96 -1.13 -4.26 -2.94
LAMA4 laminin, alpha 4 -1.44 -1.38 -1.41 -1.18
LEP leptin -2.02 -1.77 1.01 1.59
LIF leukemia inhibitory factor (cholinergic differentiation factor) 1.88 1.11 -1.03 -1.07
NR3C1 nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) 1.29 1.02 1.01 1.15
PARP2 poly (ADP-ribose) polymerase 2 1.35 1.24 1.30 1.21
PPARGC1A peroxisome proliferator-activated receptor gamma, coactivator 1 alpha 1.41 -1.09 -1.05 2.02
PTGS1 prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) -1.34 1.03 3.29 -1.59
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1.43 -2.09 -3.75 -5.58
RARA retinoic acid receptor, alpha -1.30 -2.35 1.06 -1.49
RETNLA resistin like alpha -1.32 -1.11 2.96 -10.77
SCD stearoyl-CoA desaturase (delta-9-desaturase) 1.80 1.11 1.01 1.05
TNF tumor necrosis factor 2.36 -1.48 -2.37 -2.18
TRIB2 tribbles homolog 2 2.98 1.17 1.78 -1.18
VDR vitamin D (1,25- dihydroxyvitamin D3) receptor -1.39 -1.32 -1.12 -1.21
The list includes age-related fold change in genes involved in adipocytes differentiation in bone marrow and epididymal adipocytes. The set of regulated genes
was selected according to the IPA knowledge-base. The 14-month (14M) and 18-month-old (18M) were compared to 6-month-old. The significance of differences
was measured by two-way ANOVA. The significance of differences was estimated by a Benjamini-Hochberg corrected p value (p < 0.01).
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Page 9 of 18identified 27 genes in which expression levels were signifi-
cantly altered with age in both adipocytes using a three-
way ANOVA model with p < 0.05 in the interaction of age
and cell types, as shown in Figure 5C and Table 10. A heat
map of age-altered adipocyte genes (Figure 5C) reveals
that 19 of 27 genes (70%) were regulated in the same
direction with age in both adipocyte populations. These
genes include EIF2AK3 (eukaryotic translation initiation
factor 2-alpha kinase 3), FN1 (fibronectin 1), INSIG1
(insulin induced gene 1), PNPLA2, ABHD5, GPR109A,
FABP4 and IL6 (Table 10). The other 8 genes were regu-
lated with age in both adipocyte populations, but their pat-
terns of regulation differed between bone marrow and
epididymal adipocytes. Interestingly, the list indicates that
IL6 (interleukin 6) was the most down-regulated gene
with age in 14-month-old bone marrow and epididymal
adipocytes, and GPR 109A (G protein-coupled receptor
109A) was significantly decreased 4.5 fold in 18-month-
old bone marrow and reduced 10.6 fold in 14-month-
old epididymal adipocytes compared to 6-month-old
(Table 10).
Discussion
Obesity accelerates the progression of aging and age-
related metabolic disorders such as insulin resistance and
type 2 diabetes [22,23]. The contribution of the heteroge-
neity of adipocytes to aging and age-related metabolic
syndrome has been studied in subcutaneous and visceral
adipose tissue [1,4]. Adipocytes and osteoblasts originate
from MSCs within the bone marrow, where there is a
reciprocal relationship in the development along each
lineage [5-7]. During aging, increased bone marrow adi-
pogenesis compromises hematopoietic stem cell differen-
tiation and bone remodeling [24]. This study represents
the first attempt to characterize primary bone marrow
adipocytes by gene profiling and to compare their gene
profiles with epididymal white adipocytes in response to
aging. We observed a significant increase in fat infiltra-
tion in the bone marrow in 14-month-old male mice,
which was accompanied by an increase in circulating
insulin and a decrease in osteocalcin levels, reflecting
some of the metabolic changes that occur with age.
Differential gene profiling of bone marrow adipocytes
Microarray analysis of gene expression by gene ontologies
and functional pathways allowed us not only to identify
genes differentially expressed in bone marrow adipocytes,
but also genes whose expressions were significantly altered
during aging. Recently, Majka et al performed a microar-
ray analysis of bone marrow progenitor-derived adipocytes
which were purified from peripheral adipose depots of
transplanted recipient mice by flow cytometry [20]. Their
characterization showed that bone marrow progenitor-
derived adipocytes are different from conventional white
adipocytes with low expression levels of leptin, mitochon-
d r i a la n dp e r o x i s o m a lc a p a c ity and high expression of
inflammatory genes. The study design was different from
the current study because their study examined bone mar-
row progenitor-derived adipocytes isolated from visceral
or subcutaneous depots, whereas our study examined pri-
mary adipocytes isolated directly from bone marrow. Even
with this major difference in design, our results with pri-
mary bone marrow adipocytes directly isolated from the
bone marrow of aging mice agree remarkably well with
their results. Global array analysis by PCA (Principal com-
ponent analysis) mapping showed a clear separation
between bone marrow and epididymal adipocytes. Pre-
vious studies have shown that macrophages express
Table 6 Age-related fold changes in genes involved in lipolysis
Bone marrow Epididymal
Symbol Entrez Gene Name 14M 18M 14M 18M
ABHD5 ab hydrolase domain containing 5 -1.12 -1.26 -1.97 1.04
ACACB acetyl-CoA carboxylase beta -1.40 -1.14 -2.22 -1.31
ADRB2 adrenergic, beta-2-, receptor, surface 1.22 1.49 -1.37 -2.04
C3 complement component 3 -1.07 -1.23 2.16 -1.11
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 -1.38 -1.53 -1.60 -1.15
FOXO1 forkhead box O1 1.99 1.17 -1.42 -1.44
GPR109A G protein-coupled receptor 109A -1.29 -3.99 -10.52 -2.20
NR4A1 nuclear receptor subfamily 4, group A, member 1 2.53 1.11 -4.03 -4.62
P2RY14 purinergic receptor P2Y, G-protein coupled, 14 1.07 1.05 1.54 -1.21
PDE3B phosphodiesterase 3B, cGMP-inhibited 1.57 1.25 -1.99 -1.32
PLIN1 perilipin 1 -1.24 -1.21 -1.36 1.04
PNPLA2 patatin-like phospholipase domain containing 2 -1.03 -1.43 -1.39 -1.21
TNF tumor necrosis factor 2.37 -1.38 -2.36 -2.12
The list includes age-related fold change in genes involved in lipolysis in bone marrow and epididymal adipocytes. The set of regulated genes was selected
according to the IPA knowledge-base. The 14-month (14M) and 18-month-old (18M) were compared to 6-month-old. The significance of differences was
measured by two-way ANOVA. The significance of differences was estimated by a Benjamini-Hochberg corrected p value (p < 0.01).
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Page 10 of 18several genes classically associated with adipocytes, such as
FABP4, Plin1 and PPARg [25]; yet there are distinctions
between adipocytes and macrophages. For instance, adipo-
cytes do not express the macrophage specific cell surface
marker CD11b (Mac-1a), while macrophages do not
express adiponectin [26]. The primary adipocytes isolated
from the bone marrow in our studies are characterized by
low CD11b expression and high adiponectin (>3-fold)
expression as confirmed by quantitative PCR. Expression
levels of adipocyte-specific genes (Plin1, FABP4, leptin and
Plin2) were also higher in the isolated bone marrow adipo-
cytes than bone marrow stromal cells, thus confirming
that the populations of cells studied are adipocytes.
CD11b staining also confirmed that there were similar
degrees of contamination of adipocytes by monocyte/
macrophages in preparations from bone marrow and epi-
didymal adipocytes. In our study, adipocyte specific genes
(PPARg, FABP4, Plin1, adipsin and leptin) were expressed
at significantly lower levels in bone marrow adipocytes
compared with epididymal white adipocytes, whereas the
expression levels of inflammatory genes such as IL-6 and
TNFa were found to be higher in bone marrow adipocytes
compared with epididymal white adipocytes. The
increased expression of proinflammatory cytokines in
bone marrow adipocytes might be associated with a high
level of macrophage infiltration within the aged bone mar-
row environment; however, as mentioned, we did not
detect significant differences in macrophage contamina-
tion of the adipocyte preparations isolated from bone mar-
row versus epididymal depots. Interestingly, while leptin
Table 7 Age-related fold changes in genes involved in mitochondrial function
Bone
marrow
Epididymal
Symbol Entrez Gene Name 14M 18M 14M 18M
CASP9 caspase 9, apoptosis-related cysteine peptidase 1.51 1.38 1.27 1.23
GLRX2 glutaredoxin 2 1.36 1.79 -1.05 1.38
GPX4 glutathione peroxidase 4 (phospholipid hydroperoxidase) 1.08 1.30 -1.12 -1.11
MAOB monoamine oxidase B -1.23 -1.39 -1.06 1.31
MT-ND4L NADH dehydrogenase, subunit 4L (complex I) -1.25 -1.63 -1.22 -1.17
NDUFA4 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4, 9 kDa 1.11 1.81 -1.21 1.00
NDUFA7 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5 kDa -1.72 -1.69 -1.15 1.12
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7 kDa -1.46 -1.68 -1.07 1.04
NDUFA12 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 -1.58 -1.71 -1.11 1.09
NDUFA13 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 -1.05 -1.33 -1.26 -1.30
NDUFA4L2 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 -1.26 -1.38 1.50 1.05
NDUFA9 (includes EG:4704) NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39 kDa 1.11 1.77 -1.46 1.10
NDUFAF1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1 1.18 1.87 -1.41 1.42
NDUFB8 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19 kDa -1.31 -1.40 -1.35 1.09
NDUFB10 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22 kDa -1.46 -1.38 -1.18 1.01
NDUFB11 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3 kDa -1.58 -1.38 -1.18 -1.13
NDUFS1 NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75 kDa (NADH-coenzyme Q reductase) 1.29 2.22 -1.21 1.67
NDUFS4 NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18 kDa (NADH-coenzyme Q reductase) -1.22 -1.39 -1.03 1.48
NDUFS7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20 kDa (NADH-coenzyme Q reductase) -1.53 -1.51 -1.16 -1.08
NDUFS8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23 kDa (NADH-coenzyme Q reductase) -1.37 -1.52 1.14 1.46
NDUFS6 (includes EG:4726) NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13 kDa (NADH-coenzyme Q reductase) 1.01 1.68 -1.08 1.29
NDUFV2 NADH dehydrogenase (ubiquinone) flavoprotein 2, 24 kDa -1.54 -1.31 -1.27 1.26
NDUFV3 NADH dehydrogenase (ubiquinone) flavoprotein 3, 10 kDa -1.24 -1.38 -1.11 -1.12
PDHA1 (includes EG:5160) pyruvate dehydrogenase (lipoamide) alpha 1 1.62 1.85 -1.20 1.45
PRDX3 peroxiredoxin 3 1.19 2.39 -1.42 1.19
SDHA succinate dehydrogenase complex, subunit A, flavoprotein (Fp) 1.31 1.51 -1.35 1.06
SDHB succinate dehydrogenase complex, subunit B, iron sulfur (Ip) -1.25 -1.31 -1.35 1.10
SNCA synuclein, alpha (non A4 component of amyloid precursor) -1.08 1.67 -1.16 -3.22
UQCRFS1 ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 1.20 1.49 -1.68 -1.05
UQCRH ubiquinol-cytochrome c reductase hinge protein -1.14 -1.32 -1.27 1.24
The list includes the mitochondrial genes that change with age in bone marrow and epididymal adipocytes. The set of regulated genes was selected on the
basis of their expression in adipose cells according to the IPA knowledge-base. For each gene, the fold change value in gene expression was calculated between
mean values in bone marrow adipocytes. The 14-month (14M) and 18-month-old (18M) were compared to 6-month-old. The significance of differences was
measured by two-way ANOVA.
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Page 11 of 18was expressed at a relatively lower level in bone marrow
adipocytes than in epididymal adipocytes, the leptin recep-
tor (LEPR) was more highly expressed in bone marrow
adipocytes. In addition, expression of genes involved in
fatty acid synthesis and fatty acid oxidation were lower in
bone marrow compared with epididymal adipocytes,
whereas genes associated with decreased mitochondrial
function, such as TNFa, p53, BCL2L11 and IL-1b,w e r e
significantly higher in bone marrow compared with epidi-
dymal adipocytes. Furthermore, we observed that the
Table 8 Top regulated adipocyte genes in bone marrow adipocytes with age
Symbol Entrez Gene Name 14M 18M p-value (cell type*age)
TNFa tumor necrosis factor a 2.37 -1.38 1.47E-05
FOXO1 forkhead box O1 1.99 1.17 0.0006
IRS2 insulin receptor substrate 2 1.93 -1.08 0.0008
C/EBPb CCAAT/enhancer binding protein beta 1.79 -1.23 1.22E-05
CD36 fatty acid translocase 1.38 2.00 0.001
PPARg peroxisome proliferator-activated receptor gamma 1.36 1.08 0.003
PLIN3 perilipin 3, TIP47 1.25 1.04 0.007
SOD2 superoxide dismutase 2, mitochondrial 1.24 -1.09 0.001
UCP2 uncoupling protein 2 1.24 1.18 8.1E-06
LIPE lipase, hormone sensitive 1.23 -1.27 2.1E-05
SERPINE1 plasminogen activator inhibitor type 1 1.21 -1.30 0.0004
GPX1 glutathione peroxidase 1 1.04 1.23 0.0002
SLC2A4 GLUT-4 -1.11 1.30 0.04
CFD adipsin -1.12 1.25 0.002
FABP4 fatty acid binding protein 4, adipocyte -1.52 -2.46 0.001
PTPN11 protein tyrosine11 -1.58 -1.21 0.0006
ADIPOR2 adiponectin receptor 2 -1.66 -1.44 0.001
LEPR leptin receptor -1.94 1.44 0.002
IL6 interleukin 6 (interferon, beta 2) -2.19 -1.91 8.34E-05
ADIPOQ adiponectin -2.25 -1.88 0.01
The list includes the adipocyte genes that change with age in bone marrow adipocytes. The set of regulated genes was selected on the basis of their expression in
adipose according to the IPA knowledge-base. For each gene, the fold change value in gene expression was calculated between mean values in bone marrow
adipocytes from mice. The 14-month (14M) and 18-month-old (18M) were compared to 6-month-old. The significance of differences was measured by two-way ANOVA.
Table 9 Top regulated adipocyte genes in epididymal adipocytes with age
Entrez Gene Name 14M 18M P value (cell type*age)
UCP2 uncoupling protein 2 2.3 1.3 8.1E-061
LEPR leptin receptor 1.3 -1.1 0.02
FGFR1 fibroblast growth factor receptor 1 1.3 -1.5 0.03
PLIN3 perilipin 3, TIP47 1.2 1.6 0.0007
PPARg peroxisome proliferator-activated receptor gamma 1.1 1.8 0.0003
PLIN2 Perilipin 2, adipophilin, ADFP 1 1.7 5.8E-05
ADIPOQ Adiponectin -1.2 1.2 0.01
FABP4 fatty acid binding protein 4, adipocyte -1.2 -1.3 0.05
C/EBPa CCAAT/enhancer binding protein, alpha -1.3 1.1 0.01
PPARGC1a peroxisome proliferator-activated receptor gamma, coactivator 1 alpha -1.5 2 1.4E-05
ADIPOR2 adiponectin receptor 2 -1.6 -1.1 0.001
SOD2 superoxide dismutase 2, mitochondrial -1.8 -1.1 0.0001
TNFa TNFa -2.3 -2.1 0.0001
C/EBPb CCAAT/enhancer binding protein, beta -2.4 -1 1.4E-05
IRS2 insulin receptor substrate 2 -4.3 -2.8 1.2E-05
SERPINE1 plasminogen activator inhibitor type 1 -7.3 -4.3 0.0004
IL6 interleukin 6 -19.8 -4.8 8.3E-05
The list includes the adipocyte genes that change with age in epididymal adipocytes. The set of regulated genes was selected on the basis of their expression in
adipose according to the IPA knowledge-base. For each gene, the fold change value in gene expression was calculated between mean values in epididymal
adipocytes. The 14-month (14M) and 18-month-old (18M) were compared to 6-month-old. The significance of differences was measured by two-way ANOVA.
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Page 12 of 18expression of a group of genes associated with early adipo-
cyte differentiation, including CEBP/b,K L F 4a n d
EGR1&2, INHBA and S6K1, were higher in bone marrow
adipocytes than epididymal adipocytes [27-29], indicating
that bone marrow adipocytes are in an early stage of adi-
pocyte differentiation. This observation also is supported
by low expression of Plin1 and relatively higher expression
of Plin2 in bone marrow adipocytes (14-month-old), as
Plin2 is expressed early in adipocyte differentiation [30].
Previous studies also indicated that fat cell progenitors,
preadipocytes, resemble the phenotype of macrophages.
Preadipocytes account for 15 to 50% of cells in fat tissues
[31]. Aging increases the numbers of preadipocytes and
the production of cytokines PAI, IL-6 and other proin-
flammatory cytokines [1,32]. Thus, it is possible that the
presence of newly differentiated adipocytes and fat cell
progenitor cells might contribute to the differential
expression patterns observed in bone marrow adipocytes.
Age-related gene changes in bone marrow and
epididymal adipocytes
Aging is characterized by fat redistribution with increased
visceral fat and relative loss of subcutaneous fat in humans
[22]. Microarray analysis of age-related gene expression in
white adipose tissue (WAT) has been reported in rodents
[33,34]. Linford et al reported that aging had a significant
effect on gene expression in adipose tissues, particularly
genes involved in PPARg-dependent adipogenesis and
lipid metabolism declined with age. Others have suggested
that expression levels of key adipogenic transcription fac-
tors, C/EBPa,C / E B P δ and PPARg, are lower in differen-
tiating adipocytes isolated from old compared to young
r a t s[ 3 5 ] .H e r ew eo b s e r v e dadifferential expression
between bone marrow and epididymal white adipocytes
with age. While PPARg and C/EBPb significantly increased
in 14-month-old then decreased or did not change in 18-
month-old bone marrow adipocytes, PPARg increased and
Table 10 Age-regulated adipocyte gene expression
Bone marrow Epididymal
Symbol Entrez Gene Name 14M 18M 14M 18M p-value (Age)
TRIB2 tribbles homolog 2 (Drosophila) 3.0 1.2 1.8 -1.2 1.78E-05
TNFa tumor necrosis factor a 2.4 -1.5 -2.4 -2.2 0.00013
IRS2 insulin receptor substrate 2 2.0 -1.1 -4.3 -2.9 0.00018
EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3 1.8 1.2 1.7 1.5 2.12E-06
PTGS2 prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 1.4 -2.1 -3.8 -5.6 4.87E-07
PPARGC1a peroxisome proliferator-activated receptor gamma, coactivator 1 alpha 1.4 -1.1 -1.0 2.0 0.0024
IL1b interleukin 1, beta 1.4 -1.5 -2.3 -2.2 0.00026
FN1 fibronectin 1 1.4 -1.2 7.1 -3.2 4.20E-07
PARP2 poly (ADP-ribose) polymerase 2 1.4 1.2 1.3 1.2 0.0018
CCND1 cyclin D1 1.3 1.1 2.5 -1.6 0.00062
INSIG1 insulin induced gene 1 1.3 1.5 1.3 2.8 0.0057
FGF10 fibroblast growth factor 10 1.2 1.2 -2.6 1.0 0.0031
DDIT3 DNA-damage-inducible transcript 3 1.2 -2.1 -1.8 -1.2 0.0036
C3 complement component 3 1.0 -1.4 2.1 -1.3 0.00052
PNPLA2 patatin-like phospholipase domain containing 2 -1.0 -1.6 -1.4 -1.2 0.0049
ABHD5 ab hydrolase domain containing 5 -1.0 -1.4 -2.0 -1.1 0.00059
GPR109A G protein-coupled receptor 109A -1.2 -4.5 -10.6 -2.7 2.68E-08
RARa retinoic acid receptor, alpha -1.3 -2.4 1.1 -1.5 3.42E-05
RETNLa resistin like alpha -1.3 -1.1 3.0 -10.8 8.46E-08
ARL4A ADP-ribosylation factor-like 4A -1.3 1.3 -2.0 1.0 3.30E-05
EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 -1.4 -1.6 -1.6 -1.2 0.0024
LAMA4 laminin, alpha 4 -1.4 -1.4 -1.4 -1.2 0.0065
C/EBPa CCAAT/enhancer binding protein, alpha -1.5 -1.4 -1.3 1.1 0.0062
FABP4 fatty acid binding protein 4, adipocyte -1.5 -2.6 -1.2 -1.3 0.0026
AR androgen receptor -1.8 -2.0 -1.5 -1.8 0.00026
LEP leptin -2.0 -1.8 1.0 1.6 0.0017
IL6 interleukin 6 -2.0 -2.1 -20.5 -5.6 8.65E-07
The list includes the genes that change with age in both bone marrow and epididymal adipocytes. The set of the 27 regulated genes was selected on the basis
of their fold changes across age in both adipocyte populations sorted using Partek Genome Suit software and IPA. The significance of differences was measured
by two-way ANOVA. A low value in p indicates the gene is differentially expressed with respect to age. The comparison included 14-month (14M) and 18-month-
old (18M) compared to 6-month-old.
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Page 13 of 18C/EBPb decreased at 14 and 18 months in epididymal
adipocytes. Global analysis of pathways associated with
adipogenesis and lipolysis showed that expressions of
genes within these pathways are generally increased
in 14-month-old bone marrow adipocytes, whereas they
are generally decreased in epididymal adipocytes. The
observation that the expression pattern of some genes
appears to be most highly affected at 14 months is possibly
related to changes in body weight and fat mass, as body
weights were highest at 14-months (Table 1) and declined
at 18 months (36.5 ± 1.6 gm). Moreover, it is possible
that age might have an even greater impact on differences
in gene expression patterns if older animals (24 or
30 months) were examined.
A decrease in mitochondria function is associated with
aging in heart, muscle, liver and white adipocytes in ani-
mals [36-39]. A decline in mitochondria function is highly
associated with an increase in inflammation and apoptosis
[40,41]. Linford et al reported that the most highly
induced gene changes in adipose tissue and heart with
aging in rats are genes associated with inflammation [33].
Our data are in agreement with previous reports demon-
strating an increase in inflammatory genes in both adipo-
cyte populations with age, and in particular in the bone
marrow, since the pathway analysis indicated that there
were more genes altered with age in bone marrow adipo-
cytes. We further examined whether the genes known to
be involved in aging were altered in adipocytes. For exam-
ples, SOD2 (superoxide dismutase 2) and Sirt1 (sirtuin 1),
which are associated with mitochondrial aging [42], were
significantly decreased in epididymal adipocytes with age,
whereas these changes were not seen in bone marrow adi-
pocytes. However, overall there was generally a similar
expression pattern observed in both bone marrow and epi-
didymal adipocytes in response to aging, but age has a
greater impact on global gene expression in epididymal
than in bone marrow adipocytes.
Potential functional implications of gene expression
profile of bone marrow adipocytes
In view of the physical proximity of adipocytes and osteo-
blasts within the bone marrowa n dt h ei n v e r s er e l a t i o n -
ship between bone mass and bone marrow adiposity, it
seems reasonable to speculate that adipocytes can
directly influence bone remodeling. Indeed, we have
shown that adipocytes can modulate key metabolic func-
tions of osteoblasts in co-culture through the release of
secretory products (50). Daley et al suggest that adipo-
cyte-secreted cytokines TNFa and adiponectin inhibit
hematopoietic progenitor cell expansion within the bone
marrow and also affect bone remodeling [26]. In this
regard it is noteworthy that Wdnm1-like, an adipocyte-
secreted protein, is expressed 3-4 fold higher in bone
marrow adipocytes. Smas et al reported that Wdnm1-like
is selectively expressed in adipose and liver and increases
matrix metalloproteinase 2 (MMP2) activity [43]. It is
possible that bone marrow adipocytes, through the
release of Wdnm1-like, might contribute to extracellular
remodeling within the bone marrow and mediate cross-
talk between adipocytes, mesenchymal and hematopoie-
tic stem cells. In addition to Wdnm1-like protein, we
identified a number of genes that could potentially affect
adipose-derived signaling to bone and whose expressions
are increased in bone marrow adipocytes. For instance,
the expression levels of oncostatin M (OM), SFRP4,
ABCB4, TNFa, TGFb1, GPR109A and IL-6 are markedly
increased in bone marrow adipocytes. Whereas the
actions of cytokines, such as OM, TNFa,a n dI L - 6 ,a n d
growth factors, such as TGFb1, on bone are well
described [44,45], SFRP4 is a phosphatonin that inhibits
both tubular phosphate reabsorption and Wnt signaling,
and whose expression has been reported to increase dur-
ing adipose differentiation of MSCs and to be associated
with lower bone density in mice [46-48]. Moreover,
transgenic expression of SFRP4 in osteoblasts results in
lower bone density [49]. ABCB4, also known as multi-
drug resistance P-glycoprotein 3, translocates phosphati-
dylcholine (PC) from the inner to the outer plasma
membrane, thus functioning as a PC flippase; mutations
in ABCB4 cause cholestatic liver disease [50]. Though no
specific associations of ABCB4 with bone abnormalities
are known, it is possible that adipocyte-derived PC might
be supplied to and influence differentiation of MSCs or
osteoblasts. GPR109A is the receptor for nicotinic acid,
whose endogenous ligand appears to be a product of
fatty acid oxidation, b-hydroxybutyrate [51]. This would
reduce the local release of possible PPARg or other
receptor ligands or pro-ligands and potentially have a
beneficial impact on bone. Therefore, the gene expres-
sion profile of bone marrow adipocytes is such that it
could lead to both positive and negative effects on bone.
The gene expression profile observed in 14-month-old
bone marrow adipocytes was accompanied by elevated
circulating serum insulin, glucose, adipocytokines (leptin,
adiponectin) and reduced osteocalcin. The regulation of
osteocalcin secretion by insulin has been shown in recent
studies [16]. Therefore, it is possible that the increase in
adipogenesis in the bone marrow of 14-month-old mice
induces a negative influence on MSC lineages, thereby
leading to a decline in osteoblast function, which could,
in part, be attributed to hyperinsulinemia.
Conclusions
Taken together, comparison of gene expression profiles
in bone marrow adipocytes with epididymal adipocytes
indicates that bone marrow adipocytes express adipo-
cyte-specific genes, but appear to have a gene expression
pattern that distinguishes them from epididymal
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Page 14 of 18adipocytes. Primary adipocytes within the bone marrow
are characterized by low expression levels of adipocyte-
specific genes and high levels of genes associated with
early adipocyte lineage. However, adipocytes from both
depots display common pathways and generally similar
a l t e r a t i o n si ng e n ee x p r e s s i o ni nr e s p o n s et oa g i n g .I n
depth research into the functional role of bone marrow
adipocytes will be important for uncovering age related
changes in bone, hematopoiesis and metabolic functions.
Methods
Experimental animals and isolation of adipocytes
Bone marrow adipocytes and epididymal white adipocytes
(n = 6-10 animals per group) were isolated from male
C57BL/6J mice (6-months, 14-months and 18-months of
age). All mice were housed in temperature-controlled con-
ditions on a 12-h light, 12-h dark cycle, and were fed stan-
dard chow. All procedures were in accordance with
institution guidelines and approved by the institutional
animal care and use committee of the VA Palo Alto
Health Care System. Briefly, both femurs and tibias were
collected after mice were sacrificed. Bones were cleaned
and rinsed with 75% ethanol and DEPC water to eliminate
surrounding fat and muscle cells. Fresh bone marrows
were flushed out with PBS containing 1% fatty acid-free
BSA and 1% RNAase and DNAase-free water using a 25-
gauge needle from femurs and tibias. Red blood cells were
lysed using red cell lysis buffer. After centrifugation at
3000 rpm for 5 min, floating adipocytes were collected
from bone marrow stromal cells and then were washed
with PBS buffer three times. In addition to the bone mar-
row, primary adipocytes were isolated from epididymal
white adipose tissue (WAT) as described previously [52].
Briefly, epididymal WAT was removed from mice and
minced with scissors into 2 ml Kreb-Ringer HEPES buffer
supplemented with 3% BSA. Tissues were digested with
collagenase type I (1mg/ml) for 40 min at 37°C in a 250
rpm shaker and adipocytes then isolated by flotation.
Histology
Distal femurs isolated from 6-month-old and 14-month-
old C57BL6/J male mice were decalcified in 4% EDTA
and paraffin embedded following manufacturer’ss t a n -
dard procedures (Histion, Everett, WA). Bones were sec-
tioned in the sagittal plane to obtain cross sections of
the distal femur and stained with hematoxylin and eosin
(H&E). Fields were taken from distal femur sections of
6-month-old and 14-month-old mice and adipose areas
calculated using ImagePro software.
Microarray analysis
RNA isolation, purification and array procedures
Total RNA was extracted using Trizol (Life Technolo-
gies, Grand Island, NY, USA) and chloroform followed
by purification on an RNeasy MinElute column (QIA-
GEN, Valencia, CA, USA). Three pooled RNA prepara-
tions were generated from 6-10 animals due to the low
yield of bone marrow adipocytes during isolation. RNA
quality was verified using an Agilent Bioanalyzer (Agi-
lent technologies, Palo Alto, CA, USA). Total RNA was
biotin-labeled and hybridized to the GeneChip Mouse
Gene 1.0 ST Array platform (Affymetrix, Santa Clara,
CA, USA) with three RNA preparations per age group.
The Protein and Nucleic Acid Microarray Facility at
Stanford University carried out processing of DNA
arrays according to standard protocols from the Affyme-
trix GeneChip
® W h o l eT r a n s c r i p t( W T )S e n s eT a r g e t
Labeling Assay. This assay is designed to generate
amplified and biotinylated sense-strand DNA targets
from the entire expressed genome without bias. This
assay and associated reagents have been optimized spe-
cifically for use with the GeneChip
® ST Arrays where
“ST” stands for “Sense Target” and the probes on the
arrays have been selected to be distributed throughout
the entire length of each transcript. The microarray data
files have been submitted to the Gene Expression Omni-
bus (GEO) and the accession number is GSE25905.
Statistical analysis
The raw data from microarrays were analyzed using Par-
tek
® Genome Suite software, version 6.3 Copyright
© 2008
(Partek Inc., St. Louis, MO, USA). Briefly, Affymetrix .CEL
files were processed to generate gcRMA (robust multi-
array average) values. This step was followed by quantile
normalization and log2 transformation to represent gene
expression levels. Samples were grouped into cell type
(bone marrow adipocytes vs. epididymal white adipocytes)
and age (6-month (6M), 14-month (14M) and 18-month
(18M)). ANOVA was performed including age and cell
type interaction to generate the lists of differentially
expressed genes comparing the bone marrow adipocytes
with epididymal white adipocytes with age. There were
three gene chips for each group. A total of 18 individual
arrays contributed to the analyses. Probe sets with a fold-
change 2.0 and adjusted p-value < 0.05 were considered
differentially expressed between two cell types at each age
group. The Benjamini-Hochberg false discovery rate (FDR)
method was used for false positives. A corrected p-value
cutoff of 0.05 was used to select the regulated genes with
the lowest FDR. Partek
® Genome Suite was used as the
first step for quality control (QC) of the data on all the
samples with two methods, Pearson correlation and Princi-
pal Component Analysis (PCA). PCA was performed as a
global view of sample clustering, which is related to the
total variance in gene expression for all genes. Normalized
expression values for all genes were analyzed. A selection
of 3918 genes (13%) of the 28853 well-characterized mouse
genes in Mouse Gene 1.0 ST array was differentially
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s e l e c t i o nw a sb a s e do na d j u s t e dp<0 . 0 5a n df o l dc h a n g e±
2.0. These 3918 genes were assigned to biologically mean-
ingful gene ontology (GO) categories using GO enrichment
analysis (Partek
® Genome Suite software, version 6.3).
Statistical analysis of metabolic parameters was per-
formed using Graphpad Prism 4.0. Age dependent
changes were statistically analyzed by one-way ANOVA
(repeated measures for within subject samples). Data are
presented as mean ± SE.
Pathway Analysis
For each comparison a list of differentially expressed
genes was generated. The gene lists, along with asso-
ciated expression or fold-change values, were further
analyzed using Ingenuity Pathway Analysis (Ingenuity
system, Inc, Redwood City, CA, USA) to identify differ-
entially expressed pathways between bone marrow adi-
pocytes and epididymal white adipocytes with age. The
list of significantly regulated genes selected by the
microarray analysis described above was loaded in IPA
with the following criteria: reference set: Mouse 1.0 ST
Gene assay; direct and indirect relationships included fil-
tered by species (mouse) and by tissue (adipose). Then
IPA computed the data to generate significant networks
of genes that are associated with particular biological
functions, diseases and signaling pathways.
Analysis of gene expression by real-time RT-PCR
Total RNA was extracted from cells with TriZol reagent
(Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer’s protocol. Total RNA was reverse transcribed
with random hexamers by using reverse transcriptase
(Invitrogen, Carlsbad, CA, USA). Expression of selected
adipose genes in preparations of bone marrow cells, adi-
pocytes isolated from bone marrow and adipocytes iso-
lated from epididymal white adipose tissue. A set of
original RNA from the same animal was re-amplified to
aRNA, and then converted to cDNA. After cDNA synth-
esis, mRNA expression levels were determined by using
SYBR green qPCR supermix (ABI, Foster City, CA, USA).
Expression levels of mRNA were analyzed by quantitative
real-time PCR (Prism 7900 Sequence Detection System,
Applied Biosystems (ABI), Foster City, CA, USA). Rela-
tive gene expression was calculated using the compara-
tive threshold method (2 −Δ Δ Ct) [53]. Relative fold
change was normalized to endogenous 18S and bone
marrow stromal cells. Data are presented as Log2 of fold
change. Primers are listed in Additional File 2, Table S1.
Determination of insulin and adipokine concentrations by
Luminex ELISA
Serum obtained from mice was analyzed for adipokines
and bone panel measurements using a multiplex mouse
adipokines assay (Mouse adipocyte panel, Millipore,
Bedford, MA, USA), and detected by Luminex xMAP
method (Luminex 200, Millipore, Bedford, MA, USA).
Insulin and adipokines including adiponectin, leptin,
resistin, and bone markers osteocalcin, RANKL and
osteoprotegerin were measured in 6-month and 14-
month-old mice in the fed state.
Immunostaining
Percentage of monocytes was determined by counting
the number of CD11b positive cells per 100 cells.
Approximately 200 to 400 cells were counted in each
experiment. Freshly isolated adipocytes from bone
marrow or epididymal adipose tissue were fixed with
3.7% paraformaldehyde in PBS for 1 h at room tem-
perature. Fixed cells were incubated with either BOD-
IPY 493/503 (1:500, 1 mg/mL, Molecular Probe,
Carlsbad, CA, USA) or PE (phycoerythrin) conjugated
anti-mouse CD11b (Intergrin a, Mac-1a, eBioscience
Inc, San Diego, CA, USA) at 0.124 μg per million cells
in 100 μL total staining volume and polyclonal anti
rabbit perilipin antibodies (1:200; a kind gift of Dr.
Andrew Greenberg, Tufts University) in 1% blocking
solution for 1 h. Following 1 h incubation of Alexa
555 (red) conjugated secondary antibodies at a dilution
of 1:800 at room temperature, the stained cells were
washed three to four times with PBS and observed
using a Zeiss Axio Observer A1 microscope (Carl
Zeiss, Thornwood, NY, USA).
Additional material
Additional file 1: Figure S1: Evaluation of gene expression
microarray data sets. RNA from bone marrow and epididymal white
adipocytes (three samples each age group) was converted to cDNA,
labeled and hybridized to Affymetrix Mouse Gene 1.0 ST arrays. Scanned
data were imported into Partek Genomics Suit Software and normalized
using RMA algorithim. A plot of frequency versus signal value is shown
for each dataset.
Additional file 2: Table S1: List of primers for qRT-PCR.
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